Artikel in der Pharmazeutischen Zeitung

 

In der Pharmazeutischen Zeitung zum findet sich ein Artikel zum Thema "Lieferengpässe"

In dem Artikel wird darüber informiert, dass unser Institutsleiter Herr Professor Dr. med Roland Seifert  Nachforschungen über die betroffenen Facharztgruppen, sowie die aufgwendetete Zeit der Patientenversorgung anstellen wird

Link zum Artikel

Lieferengpässe kosten Ärzte 30 bis 45 Minuten pro Wirkstoff

Interview im Tagesspiegel

In einem Interview mit der Berliner Zeitung „Tagesspiegel“ erläutert Prof. Seifert, welche Medikamente an heißen Tagen zu einem Problem werden und in ihrer Wirkung verstärkt werden können:

Link zum Artikel im Tagesspiegel:

https://www.tagesspiegel.de/gesundheit/von-antidepressiva-bis-ibuprofen-diese-medikamente-konnen-bei-hitze-zum-problem-werden-15896739.html

Auszeichnung Trainee-Autor für Juli 2026 Molekulare Pharmakologie

Lilly Josephine Bindel, Medizinstudentin und Doktorandin am Institut für Pharmakologie, wurde im Juli 2027 von der Zeitschrift Molecular Pharmacology als "Highlighted Trainee Author" (HTA) ausgezeichnet, ein Journal der American Society for Pharmacology and Experimental Therapeutics (ASPET). Die Auszeichnung würdigt eine vor Kurzem veröffentlichte Publikation.

Link zur Publikation


10. Europäischer Kongress Pharmakologie

Vom 9.-11. März .2027  findet in Frankfurt der 10. Europäischer Kongress Pharmakologie statt.

Link zur EPHAR-Webseite

https://www.ephar.eu

Arzneiverordnungs-Report 2025

Der neue Arzneiverordnungs-Report für 2025 ist erschienen

 

Arzneiverordnungs-Report 2025 | Springer Nature Link


Neueste Publikationen

Heck EMGärditz KFSeifert R.

Court rulings on medication errors in Germany: focus on heparin, acetylsalicylic acid, and oxytocin. Naunyn Schmiedebergs Arch Pharmacol. 2026 Aug 29. doi: 10.1007/s00210-026-05808-6. Epub ahead of print.

Bindel LJ,  Seifert R.

Repurposing of colchicine: critical examination of clinical trials and scoping review. Eur J Clin Pharmacol. 2026 Aug 20;82(9):238. doi: 10.1007/s00228-026-04149-w. PMID: 42618809

Gezgin F, Eyer F, Zorn G, Schaper A, Wagner R, Seifert. R

Pseudoephedrine poisoning reported to German poison centers: analysis of documented patient cases and the particular vulnerability of infants and toddlers. Naunyn Schmiedebergs Arch Pharmacol. 2026 Aug 6. doi: 10.1007/s00210-026-05790-z. Epub ahead of print. 

Hitsch F,  Seifert R

Correction to: Critical analysis of withdrawn drug applications in marketing authorization procedures of the European Medicines Agency (EMA) 2006-2024. Naunyn Schmiedebergs Arch Pharmacol. 2026 Aug;399(11):17423. doi: 10.1007/s00210-026-05562-9. Erratum for: Naunyn Schmiedebergs Arch Pharmacol. 2026 Aug;399(11):17409-17421. doi: 10.1007/s00210-026-05443-1. PMID: 42252342; 

Rotter JM,  Seifert R

Drug supply shortages and their consequences for the medical profession: a survey in Germany and Austria. Naunyn Schmiedebergs Arch Pharmacol. 2026 Aug;399(11):18157-18179. doi: 10.1007/s00210-026-05484-6. Epub 2026 Jun 6. PMID: 42249097; 

Hitsch F,  Seifert R

Critical analysis of withdrawn drug applications in marketing authorization procedures of the European Medicines Agency (EMA) 2006-2024. Naunyn Schmiedebergs Arch Pharmacol. 2026 Aug;399(11):17409-17421. doi: 10.1007/s00210-026-05443-1. Epub 2026 May 22. Erratum in: Naunyn Schmiedebergs Arch Pharmacol. 2026 Aug;399(11):17423. doi: 10.1007/s00210-026-05562-9. PMID: 42171747; PMCID: PMC13503448.

Bindel LJ,  Seifert R.

US postmarketed drug removals: Analysis of discontinued and withdrawn drugs. J Pharmacol Exp Ther. 2026 Jul 31;393(9):104996. doi: 10.1016/j.jpet.2026.104996. Epub ahead of print.

Bindel LJ,  Seifert R.

Correction: AWaRe classification analysis for European countries with ARIMA forecasts to assess prescribing patterns and 'One Health' targets. Naunyn Schmiedebergs Arch Pharmacol. 2026 Jul 30. doi: 10.1007/s00210-026-05776-x. Epub ahead of print. Erratum for: Naunyn Schmiedebergs Arch Pharmacol. 2025 Oct;398(10):13707-13729. doi: 10.1007/s00210-025-04121-y. 

McGuigan AS,  Seifert R.

The evolution of pharmacological recommendations for anaphylaxis: a comparative analysis of established textbooks. Naunyn Schmiedebergs Arch Pharmacol. 2026 Jul 27. doi: 10.1007/s00210-026-05734-7. Epub ahead of print.

Bindel LJ,  Seifert R.

Comparison of essential drug lists: concordance, differences, and the need for core lists in times of crisis. Naunyn Schmiedebergs Arch Pharmacol. 2026 Jul 15. doi: 10.1007/s00210-026-05698-8. Epub ahead of print. PMID: 42448933.

Seifert R EI-Mas MM, Hattory,  Kapoor DU

 A new chapter in the history of Naunyn-Schmiedebergs Archives of Pharmacology: appointment of international deputy editors. Naunyn Schmiedebergs Arch Pharmacol. 2026 Jul 1. doi: 10.1007/s00210-026-05641-x. Epub ahead of print. 

Bindel LJ,  Seifert R.

Comparative analysis of ligand binding affinities and functional profiles at recombinant human β-adrenergic receptor subtypes 1, 2, and 3. J Pharmacol Exp Ther. 2026 Jul;393(7):104960. doi: 10.1016/j.jpet.2026.104960. Epub 2026 Jun 8.

Bindel LJ,  Seifert R.

Binding affinities for histamine receptors 1 to 4: Systematic comparison of ligands from the Psychoactive Drug Screening Program Ki database and International Union of Basic and Clinical Pharmacology/British Pharmacological Society Guide to Pharmacology. Mol Pharmacol. 2026 Jul;108(7):100139. doi: 10.1016/j.molpha.2026.100139. Epub 2026 Jun 12.

Manfouo B,  Seifert R.

Correction to: New drugs and their performance 10 years after approval: a systematic analysis. Naunyn Schmiedebergs Arch Pharmacol. 2026 Jul;399(10):16589-16593. doi: 10.1007/s00210-026-05372-z. Erratum for: Naunyn Schmiedebergs Arch Pharmacol. 2025 Nov;398(11):15515-15534. doi: 10.1007/s00210-025-04178-9. PMID: 

Ecker PAM Seifert RSchaper A, Bräuning HJ, Seifert R

 Critical analysis of digitalis glycosides: declining use but increasing poison-center exposure cases for digitoxin. Eur J Clin Pharmacol. 2026 Jun 23;82(7):186. doi: 10.1007/s00228-026-04099-3. PMID: 42334625; PMCID: PMC13290837.

Ried PFGSeifert R

Drug-induced gingival overgrowth: evaluation of an online survey. Naunyn Schmiedebergs Arch Pharmacol. 2026 Jun 20. doi: 10.1007/s00210-026-05600-6. Epub ahead of print. PMID: 42321579

Joshua Kinzel,Seifert R

A Survey of German Dentists on the Prophylactic Use of Antibacterial Drugs in Patients in Risk Groups: Diabetes, Joint Replacement, Risk of Endocarditis, and Immunosuppression or Organ Transplantation. Int J Dent. 2026 Jun 19;2026:8452465. doi: 10.1155/ijod/8452465. PMID: 42325694; PMCID: PMC13280459. 

Bindel LJ, Seifert R

Pharmacological assessment of drugs retained in the 1st and 24th WHO Essential Medicines List (1977-2025). Naunyn Schmiedebergs Arch Pharmacol. 2026 Jun 17. doi: 10.1007/s00210-026-05555-8. Epub ahead of print. PMID: 42307638.

Rotter JMSeifert R

Drug supply shortages and their consequences for the medical profession: a survey in Germany and Austria. Naunyn Schmiedebergs Arch Pharmacol. 2026 Jun 6. doi: 10.1007/s00210-026-05484-6. Epub ahead of print.

Donner K,  Seifert R

Selenium containing dietary supplements: Market-, efficacy- and risk analysis. J Trace Elem Med Biol. 2026 Jun;95:127903. doi: 10.1016/j.jtemb.2026.127903. Epub 2026 Jun 1. PMID: 42241865.

Schmoll ESeifert R

Pharmacological content in the television series "House MD": analysis from a German pharmacologist's perspective. Naunyn Schmiedebergs Arch Pharmacol. 2026 Apr;399(7):10615-10641. doi: 10.1007/s00210-026-04995-6. Epub 2026 Feb 7. PMID: 41652009;

Ried PFGSeifert R

Social media data and its potential for pharmacovigilance: a comparative analysis of reported prevalences regarding drug-induced gingival overgrowth (DIGO). Naunyn Schmiedebergs Arch Pharmacol. 2026 Apr;399(7):9673-9694. doi: 10.1007/s00210-026-04983-w. Epub 2026 Jan 23. 

Krug E, Seifert R

Analysis of the use of trade names versus active ingredient names using the example of acetylsalicylic acid and Aspirin® in the Frankfurter Allgemeine Zeitung. Naunyn Schmiedebergs Arch Pharmacol. 2026 Apr;399(7):9585-9606. doi: 10.1007/s00210-025-04788-3. Epub 2026 Jan 22. PMID: 41565878; PMCID: PMC13152897.

Hitsch F, Seifert R

Correction to: Critical analysis of withdrawn drug applications in marketing authorization procedures of the European Medicines Agency (EMA) 2006-2024. Naunyn Schmiedebergs Arch Pharmacol. 2026 Jun 8. doi: 10.1007/s00210-026-05562-9. Epub ahead of print. Erratum for: Naunyn Schmiedebergs Arch Pharmacol. 2026 May 22. doi: 10.1007/s00210-026-05443-1. PMID: 42252342.

Rotter JM, Seifert R

Drug supply shortages and their perceived consequences for patients: a questionnaire survey of German and Austrian physicians, Eur J Clin Pharmacol, 2026 May 1;82(5):138., doi: 10.1007/s00228-026-04052-4.

Tödter AL, Seifert R.

Critical analysis of the prescription and evaluation of monoclonal antibodies approved in Germany for the outpatient setting from 2010-2021, Naunyn Schmiedebergs Arch Pharmacol 2026 Apr 7.doi: 10.1007/s00210-026-05201-3. Epub Online ahead of print.

Bindel LJ, Seifert R.

US Food and Drug Administration black box warnings: Characteristics of drug classes and adverse effects, J Pharmacol Exp Ther 2026 Apr;393(4):104317. doi: 10.1016/j.jpet.2026.104317. Epub 2026 Mar 16., 

Steinert, JM, Seifert R

A brief history of the German Society for Experimental and Clinical Pharmacology and Toxicology-an overview of available sources, Naunyn Schmiedebergs Arch Pharmacol 2026 Mar 28, doi: 10.1007/s00210-026-05197-w. Epub ahead of print. PMID: 41896404

Steinert, JM, Seifert R

Correction: The Schmiedeberg Medal of the German Society for Experimental and Clinical Pharmacology and Toxicology: a biographical and bibliometric analysis of the 47 recipients from 1956 to 2024, Naunyn Schmiedebergs Arch Pharmacol 2026 Mar 24, doi: 10.1007/s00210-026-05256-2. Epub Online ahead of print. PMID: 41872589

Bindel LJ, Seifert R.

Antidepressant drug use in Europe: past consumption, prescribing patterns and forecast until 2030, Int J Clin Pharm, 2026 Mar 10. doi: 10.1007/s11096-025-02078-9. Epub Online ahead of print., PMID: 4180613

Rotter JMSeifert R

Drug supply shortages and their consequences for the medical profession: a survey in Germany and Austria. Naunyn Schmiedebergs Arch Pharmacol. 2026 Jun 6. doi: 10.1007/s00210-026-05484-6. Epub ahead of print.

Donner K,  Seifert R

Selenium containing dietary supplements: Market-, efficacy- and risk analysis. J Trace Elem Med Biol. 2026 Jun;95:127903. doi: 10.1016/j.jtemb.2026.127903. Epub 2026 Jun 1. PMID: 42241865.

Schmoll ESeifert R

Pharmacological content in the television series "House MD": analysis from a German pharmacologist's perspective. Naunyn Schmiedebergs Arch Pharmacol. 2026 Apr;399(7):10615-10641. doi: 10.1007/s00210-026-04995-6. Epub 2026 Feb 7. PMID: 41652009;

Ried PFGSeifert R

Social media data and its potential for pharmacovigilance: a comparative analysis of reported prevalences regarding drug-induced gingival overgrowth (DIGO). Naunyn Schmiedebergs Arch Pharmacol. 2026 Apr;399(7):9673-9694. doi: 10.1007/s00210-026-04983-w. Epub 2026 Jan 23. 

Krug E, Seifert R

Analysis of the use of trade names versus active ingredient names using the example of acetylsalicylic acid and Aspirin® in the Frankfurter Allgemeine Zeitung. Naunyn Schmiedebergs Arch Pharmacol. 2026 Apr;399(7):9585-9606. doi: 10.1007/s00210-025-04788-3. Epub 2026 Jan 22. PMID: 41565878; PMCID: PMC13152897.

Hitsch F, Seifert R

Correction to: Critical analysis of withdrawn drug applications in marketing authorization procedures of the European Medicines Agency (EMA) 2006-2024. Naunyn Schmiedebergs Arch Pharmacol. 2026 Jun 8. doi: 10.1007/s00210-026-05562-9. Epub ahead of print. Erratum for: Naunyn Schmiedebergs Arch Pharmacol. 2026 May 22. doi: 10.1007/s00210-026-05443-1. PMID: 42252342.

Rotter JM, Seifert R

Drug supply shortages and their perceived consequences for patients: a questionnaire survey of German and Austrian physicians, Eur J Clin Pharmacol, 2026 May 1;82(5):138., doi: 10.1007/s00228-026-04052-4.

Tödter AL, Seifert R.

Critical analysis of the prescription and evaluation of monoclonal antibodies approved in Germany for the outpatient setting from 2010-2021, Naunyn Schmiedebergs Arch Pharmacol 2026 Apr 7.doi: 10.1007/s00210-026-05201-3. Epub Online ahead of print.

Bindel LJ, Seifert R.

US Food and Drug Administration black box warnings: Characteristics of drug classes and adverse effects, J Pharmacol Exp Ther 2026 Apr;393(4):104317. doi: 10.1016/j.jpet.2026.104317. Epub 2026 Mar 16., 

Steinert, JM, Seifert R

A brief history of the German Society for Experimental and Clinical Pharmacology and Toxicology-an overview of available sources, Naunyn Schmiedebergs Arch Pharmacol 2026 Mar 28, doi: 10.1007/s00210-026-05197-w. Epub ahead of print. PMID: 41896404

Steinert, JM, Seifert R

Correction: The Schmiedeberg Medal of the German Society for Experimental and Clinical Pharmacology and Toxicology: a biographical and bibliometric analysis of the 47 recipients from 1956 to 2024, Naunyn Schmiedebergs Arch Pharmacol 2026 Mar 24, doi: 10.1007/s00210-026-05256-2. Epub Online ahead of print. PMID: 41872589

Bindel LJ, Seifert R.

Antidepressant drug use in Europe: past consumption, prescribing patterns and forecast until 2030, Int J Clin Pharm, 2026 Mar 10. doi: 10.1007/s11096-025-02078-9. Epub Online ahead of print., PMID: 4180613

 

Home

Zur Startseite

Home
Kontakt

Unsere Mitarbeiter*innen

Kontakt
Lehre

Lehraktivitäten, Doktorarbeiten und Weiterbildungsmöglichkeiten

Lehre
Forschungsschwerpunkte

Zyklische Nukleotide, Histamin-H4-Rezeptor

Forschung
Publikationen

Publikationen des Instituts (2021-2025)

Publikationen
Zentrale Forschungseinrichtung Metabolomics

GC- und LC-MS/MS-Analytik

Metabolomics